Similar articles

• Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment.

  Haddad R, Tishler RB, Norris CM, Mahadevan A, Busse P, Wirth L, Goguen LA, Sullivan CA, Costello R, Case MA, Posner MR. Haddad R, et al. Oncologist. 2003;8(1):35-44. doi: 10.1634/theoncologist.8-1-35. Oncologist. 2003. PMID: 12604730 Review.
• Neoadjuvant chemotherapy prior to surgery in head and neck cancer.

  Paterson C, Robertson AG, Grose D, Correa PD, Rizwanullah M. Paterson C, et al. Clin Oncol (R Coll Radiol). 2012 Feb;24(1):79-80. doi: 10.1016/j.clon.2011.09.016. Epub 2011 Nov 8. Clin Oncol (R Coll Radiol). 2012. PMID: 22070911 No abstract available.
• Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.

  Brizel DM, Prosnitz RG, Hunter S, Fisher SR, Clough RL, Downey MA, Scher RL. Brizel DM, et al. Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1418-23. doi: 10.1016/j.ijrobp.2003.09.004. Int J Radiat Oncol Biol Phys. 2004. PMID: 15050318
• [Four cases of hypopharyngeal cancer treated with docetaxel, cisplatin, and 5-FU followed by radiotherapy and/or neck dissection].

  Miyahara H, Nario K, Matsushiro N, Sasai H, Kajikawa H. Miyahara H, et al. Gan To Kagaku Ryoho. 2004 May;31(5):739-42. Gan To Kagaku Ryoho. 2004. PMID: 15170983 Japanese.
• Neoadjuvant chemotherapy in head and neck cancer: should it be revisited?

  Specenier PM, Vermorken JB. Specenier PM, et al. Cancer Lett. 2007 Oct 28;256(2):166-77. doi: 10.1016/j.canlet.2007.06.015. Epub 2007 Jul 27. Cancer Lett. 2007. PMID: 17673364 Review.